Is Sunitinib available in the country?

Sunitinib (Sunitinib)The original research was approved by the State Food and Drug Administration in 2007 and launched in China. Sunitinib is an oral small molecule, multi-target anti-cancer drug. The active ingredient Sunitinib exists in the form of malate in sunitinib capsules. By using this drug, it can inhibit the formation of tumor blood vessels and play an anti-tumor cell growth role. Its trade name is sunitinib Sutent, which is used to treat gastrointestinal stromal tumor (GIST), renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST). Sunitinib is the first cancer drug approved for two different indications simultaneously.